Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Agrawal M

18 indexed publications match this author name.

ORCID: 0000-0002-0727-6822
OpenAlex: https://openalex.org/A5075438055

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 16 Clinical Trial 15 Safety 11 Cancer Patients 8 Observational Study 5 PTSD 5 Adverse Events 4 Drug Interactions 3 Anxiety 3 Aging 2 Chronic Pain 2 Headache / Migraine 2

Journals

Cancer 3 Journal of Clinical Oncology 2 Journal of pain and symptom management 1 Healthcare 1 Psychedelic medicine (New Rochelle, N.Y.) 1 Neuroscience Applied 1 Journal of psychopharmacology (Oxford, England) 1 EClinicalMedicine 1

Publication history

Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis.Journal of pain and symptom management · 2026-08-03 Developing Methods for Observing Awe Narration in Psilocybin-Assisted TherapyHealthcare · 2026-06-05 Meaning-Centered Psychotherapy for Psilocybin-Assisted Therapy Among Patients with Advanced Cancer and Depression: Rationale and Preliminary Evaluation of MCP-PSIL.Psychedelic medicine (New Rochelle, N.Y.) · 2026-06-01 An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomesNeuroscience Applied · 2026-01-01 Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.Journal of psychopharmacology (Oxford, England) · 2026-01-01 Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.EClinicalMedicine · 2025-12-01 “To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group TherapyPsychedelic Medicine · 2025-08-25 Long-term benefits of single-dose psilocybin in depressed patients with cancer.Cancer · 2025-06-15 Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.General hospital psychiatry · 2025-01-01 Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.International review of psychiatry (Abingdon, England) · 2024-12-01 Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis.Cancer · 2024-04-01 Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.Cancer · 2024-04-01 Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study.Journal of palliative medicine · 2023-12-01 Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder.JAMA oncology · 2023-06-01 Long term efficacy of psilocybin in patients with cancer and major depressive disorder (MDD).Journal of Clinical Oncology · 2023-05-31 Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients.Journal of affective disorders · 2023-02-15 Group psychedelic therapy: empirical estimates of cost-savings and improved access.Frontiers in psychiatry · 2023-01-01 The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder.Journal of Clinical Oncology · 2022-05-31

Author directory